Login / Signup
Tatjana Zekić
ORCID
Publication Activity (10 Years)
Years Active: 2017-2023
Publications (10 Years): 4
Top Topics
Monoclonal Antibody
Liver Injury
Interstitial Lung Disease
Particulate Matter
Top Venues
Rheumatology international
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Tatjana Zekić
Rituximab as the first-line therapy in anti-synthetase syndrome-related interstitial lung disease.
Rheumatology international
(2023)
Tatjana Zekić
,
Mirjana Stanić Benić
Anti-programmed death-1 inhibitor nivolumab-induced immune-related adverse events: hepatitis, renal insufficiency, myositis, vitiligo, and hypothyroidism: a case-based review.
Rheumatology international
(2022)
Tatjana Zekić
,
Mirjana Stanić Benić
,
Mislav Radic
Treatment of rheumatoid arthritis with conventional, targeted and biological disease-modifying antirheumatic drugs in the setting of liver injury and non-alcoholic fatty liver disease.
Rheumatology international
42 (10) (2022)
Tatjana Zekić
Cardiac involvement in eosinophilic granulomatosis with polyangiitis.
Rheumatology international
38 (4) (2017)